Amy O'Leary Vandekop, insider filing for KLRS
Amy O'Leary Vandekop, reporting
Every EDGAR filing for Kalaris Therapeutics, Inc. (KLRS), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Amy O'Leary Vandekop, insider filing for KLRS
Amy O'Leary Vandekop, reporting
Laurie Keating, insider filing for KLRS
Laurie Keating, reporting
Amy O'Leary Vandekop, new insider at KLRS
Amy O'Leary Vandekop, reporting
Liisa Ann Bayko, insider filing for KLRS
Liisa Ann Bayko, reporting
Morana Jovan-Embiricos, insider filing for KLRS
Morana Jovan-Embiricos, reporting
Ownership stake disclosure by Samsara BioCapital, L.P. (amended)
Samsara BioCapital, L.P., filed by
Srinivas Akkaraju, insider filing for KLRS
Srinivas Akkaraju, reporting · Samsara BioCapital, L.P., reporting · +3 more
Securities offering
Brett R Hagen, insider filing for KLRS
Brett R Hagen, reporting
Brett R Hagen, planned sale of KLRS shares
Brett R Hagen, reporting
Matthew Gall, insider filing for KLRS
Matthew Gall, reporting
Srinivas Akkaraju, insider filing for KLRS
Srinivas Akkaraju, reporting · Samsara BioCapital, L.P., reporting · +3 more
Ownership stake disclosure by Samsara BioCapital, L.P. (amended)
Samsara BioCapital, L.P., filed by
Ownership stake disclosure by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP, filed by
Ownership stake disclosure by Samsara BioCapital, L.P. (amended)
Samsara BioCapital, L.P., filed by
Srinivas Akkaraju, insider filing for KLRS
Srinivas Akkaraju, reporting · Samsara Opportunity Fund, L.P., reporting · +1 more